Sola Civil Hospital
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
| Sola Civil Hospital | |
|---|---|
| Geography | |
| Location | Sola, Ahmedabad, Gujarat, India |
| Organisation | |
| Care system | Public |
| Type | General |
| Services | |
| Emergency department | Yes |
| Links | |
| Website | GMERS Sola-Hospital |
Sola Civil Hospital is a public hospital located in the Sola area of Ahmedabad, Gujarat, India.[1]
Overview[edit]
The hospital provides comprehensive healthcare services, ranging from general medical care to specialised treatments. The hospital includes departments such as cardiology, neurology, orthopedics, pediatrics, and gynecology. Sola Civil Hospital aims to provide affordable healthcare, especially for disadvantaged sections of society. [2] [3] [4]
Services and facilities[edit]
Equipped with modern medical technology, the hospital offers emergency services, outpatient and inpatient care, and surgical procedures. It has also undertaken clinical trials of Covaxin, the covid vaccine developed in India.[5]
Community outreach[edit]
The hospital engages in public health initiatives and disease prevention campaigns. The hospital also organises free or subsidised health camps for underprivileged communities.[6]
Reference[edit]
- ^ "Sola Civil's Rs 40-cr 'corporate' makeover". Ahmedabad Mirror. Retrieved 2024-03-22.
- ^ "Razing of Sola Civil building delayed due to internal row". Ahmedabad Mirror. Retrieved 2024-03-22.
- ^ "Ahmedabad: Fire safety gear installation only half done at Sola Civil Hospital". The Times of India. 2020-11-28. ISSN 0971-8257. Retrieved 2024-03-22.
- ^ "Botched up surgery alleged at Sola Civil hospital". The Times of India. 2016-08-09. ISSN 0971-8257. Retrieved 2024-03-22.
- ^ "Ahmedabad: Power outage in Sola Civil Hospital troubles patients, relatives". The Times of India. 2022-06-28. ISSN 0971-8257. Retrieved 2024-03-22.
- ^ "Sola Civil Hospital in Ahmedabad begins Phase-3 trial of Covaxin". The Times of India. 2020-11-27. ISSN 0971-8257. Retrieved 2024-03-22.
See also[edit]
 | This health-related article is a stub. You can help Wikipedia by expanding it. |